References
- Mueser T. K., Yarnold P. R., Levinson D. F., Singh H., Bellack A. S., Kee K., Morrison L., Yadalam K. G. Prevalence of substance abuse in schizophrenia: Demographic and clinical correlates. Schizophrenia Bulletin 1990; 16: 31–56
- Dixon L., Haas G., Weiden P., Sweeney J., Frances A. J. Drug abuse in schizophrenic patients: Clinical correlates and reasons for use. American Journal of Psychiatry 1991; 148: 224–230
- Stone A. M., Greenstein R. A., Gamble G., McLellan T. Cocaine use by schizophrenic outpatients who receive depot neuroleptic medication. Hospital and Community Psychiatry 1993; 44: 176–177
- Hancock L., Walsh R., Henry D. A., Redman S., Sanson-Fisher R. Drug use in Australia: A community prevalence study. Medical Journal of Australia 1992; 156: 759–764
- Dixon L., Haas G., Weiden P., Sweeney J., Frances A. Acute effects of drug abuse in schizophrenic patients: Clinical observations and patients' self-reports. Schizophrenia Bulletin 1990; 16: 69–79
- Schneier F. R., Siris S. G. A review of psychoactive substance abuse in schizophrenia. Patterns of drug choice. Journal of Nervous and Mental Disease 1987; 175: 641–652
- Cuffel B. J., Heithoff K. A., Lawson W. Correlates of patterns of substance abuse among patients with schizophrenia. Hospital and Community Psychiatry 1993; 44: 247–251
- Khantzian E. J. The self-medication hypothesis of addictive disorders. Focus on heroin and cocaine dependence. American Journal ofPsychiatry 1985; 142: 1259–1264
- Derogatis L. R., Spencer B. S. The Brief Symptom Inventory (BSI). Administration, scoring and procedures manual. Clinical Psychometric Research, Baltimore 1982
- Test M. A., Wallisch L. S., Allness D. J., Ripp K. Substance abuse in young adults with schizophrenic disorders. Schizophrenia Bulletin 1989; 15: 465–476
- Regier D. A., Farmer M. E., Rae D. S., Locke B. Z., Keith S. J., Judd L. L., Goodwin K. G. Comorbidity of mental disorders with alcohol and other substance abuse: Results of the Epidemiologic Catchment Area (ECA) survey. Journal of the American Medical Association 1990; 246: 2511–2518
- Mathers D. C., Ghodse A. H. Cannabis and psychotic illness. British Journal of Psychiatry 1992; 161: 648–653
- Strang J., Johns A., Caan W. Cocaine in the UK - 1991. British Journal of Psychiatry 1993; 162: 1–13
- Zisook S., Heaton R., Moranville J., Kuck M. A., Jernigan T., Braff D. Past substance abuse and the clinical course of schizophrenia. American Journal ofPsychiatry 1992; 149: 552–553
- Cleghorn J. M., Kaplan R. D., Szechtman B., Szechtman H., Brown G. M., Franco S. Substance abuse and schizophrenia: Effect on symptoms but not on neurocognitive function. Journal of Clinical Psychiatry 1991; 52: 26–30
- Sevy S., Kay S. R., Opler L. A., Van Praag H. M. Significance of cocaine history in schizophrenia. Journal of Nervous and Mental Disease 1990; 178: 642–648
- Thornicroft G. Cannabis and psychosis. Is there epidemiological evidence for an association? British Journal of Psychiatry 1990; 157: 25–33
- Van Kammen D., Boronow J. J. Dextro-amphetamine diminishes negative symptoms in schizophrenia. International Clinical Psychopharmacology 1988; 3: 111–121
- Rosenthal R. N., Hellerstein D. J., Miner C. R. Integrated services for treatment of schizophrenic substance abusers: Demographics, symptoms, and substance abuse patterns. Psychiatric Quarterly 1992; 63: 3–26